Stephen Johnson

Array ( [id] => 4772767 [patent_doc_number] => 20080058426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'COMPOSITION AND METHOD FOR TREATING PSORIASIS' [patent_app_type] => utility [patent_app_number] => 11/616189 [patent_app_country] => US [patent_app_date] => 2006-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 864 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058426.pdf [firstpage_image] =>[orig_patent_app_number] => 11616189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005572 [patent_doc_number] => 20070203144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Use of Memantine and Brimonidine to Attenuate Vitreoretinal Vascular Endothelial Growth Factor (VEGF) Protein Levels in Animals' [patent_app_type] => utility [patent_app_number] => 11/615876 [patent_app_country] => US [patent_app_date] => 2006-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4275 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203144.pdf [firstpage_image] =>[orig_patent_app_number] => 11615876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10579808 [patent_doc_number] => 09301919 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-05 [patent_title] => 'Sublimable sustained release delivery system and method of making same' [patent_app_type] => utility [patent_app_number] => 11/615048 [patent_app_country] => US [patent_app_date] => 2006-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8263 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11615048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5022259 [patent_doc_number] => 20070148225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE' [patent_app_type] => utility [patent_app_number] => 11/614910 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4956 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20070148225.pdf [firstpage_image] =>[orig_patent_app_number] => 11614910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4866344 [patent_doc_number] => 20080145403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Low temperature processes for making cyclic lipid implants for intraocular use' [patent_app_type] => utility [patent_app_number] => 11/612928 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17516 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145403.pdf [firstpage_image] =>[orig_patent_app_number] => 11612928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4866346 [patent_doc_number] => 20080145405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'DRUG DELIVERY DEVICES' [patent_app_type] => utility [patent_app_number] => 11/611674 [patent_app_country] => US [patent_app_date] => 2006-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7467 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145405.pdf [firstpage_image] =>[orig_patent_app_number] => 11611674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4866366 [patent_doc_number] => 20080145425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'PHARMACEUTICAL COMPOSITION OF ZOLPIDEM' [patent_app_type] => utility [patent_app_number] => 11/611305 [patent_app_country] => US [patent_app_date] => 2006-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5330 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145425.pdf [firstpage_image] =>[orig_patent_app_number] => 11611305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5119377 [patent_doc_number] => 20070141091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'BIGUANIDE OINTMENT AND METHOD OF TREATMENT AND PREVENTION OF INFECTIONS' [patent_app_type] => utility [patent_app_number] => 11/610893 [patent_app_country] => US [patent_app_date] => 2006-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4037 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141091.pdf [firstpage_image] =>[orig_patent_app_number] => 11610893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5119378 [patent_doc_number] => 20070141092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'BIGUANIDE COMPOSITION AND METHOD OF TREATMENT AND PREVENTION OF VIRAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 11/610912 [patent_app_country] => US [patent_app_date] => 2006-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4244 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141092.pdf [firstpage_image] =>[orig_patent_app_number] => 11610912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9882651 [patent_doc_number] => 08969415 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'Intraocular drug delivery systems' [patent_app_type] => utility [patent_app_number] => 11/565917 [patent_app_country] => US [patent_app_date] => 2006-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 23361 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11565917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5119434 [patent_doc_number] => 20070141148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Neramexane MR matrix tablet' [patent_app_type] => utility [patent_app_number] => 11/604986 [patent_app_country] => US [patent_app_date] => 2006-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9456 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141148.pdf [firstpage_image] =>[orig_patent_app_number] => 11604986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4758960 [patent_doc_number] => 20080311186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Composition Having Effect on Treatment and Prevention of Dry Eye Syndrome' [patent_app_type] => utility [patent_app_number] => 12/094742 [patent_app_country] => US [patent_app_date] => 2006-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5475 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311186.pdf [firstpage_image] =>[orig_patent_app_number] => 12094742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5236113 [patent_doc_number] => 20070128270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'PHARMACEUTICAL FORMULATIONS CONTAINING 5-CYCLOPROPYL-2-(4-FLUOROPHENYL)-6-[(2-HYDROXYETHYL)(METHYLSULFONYL)AMINO]-N-METHYL-1-BENZOFURAN-3-CARBOXAMIDE AND METHOD OF MAKING THE SAME' [patent_app_type] => utility [patent_app_number] => 11/558388 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6406 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128270.pdf [firstpage_image] =>[orig_patent_app_number] => 11558388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4964893 [patent_doc_number] => 20080107713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Contact lens as a sustained drug delivery implant' [patent_app_type] => utility [patent_app_number] => 11/594518 [patent_app_country] => US [patent_app_date] => 2006-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1661 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107713.pdf [firstpage_image] =>[orig_patent_app_number] => 11594518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5034133 [patent_doc_number] => 20070098672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Fogger propellant system for containing and dispersing antimicrobial and air freshening compounds' [patent_app_type] => utility [patent_app_number] => 11/591814 [patent_app_country] => US [patent_app_date] => 2006-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1457 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20070098672.pdf [firstpage_image] =>[orig_patent_app_number] => 11591814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4964915 [patent_doc_number] => 20080107735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Macrocyclic formulations for transmembrane drug delivery' [patent_app_type] => utility [patent_app_number] => 11/591788 [patent_app_country] => US [patent_app_date] => 2006-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9588 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107735.pdf [firstpage_image] =>[orig_patent_app_number] => 11591788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5215688 [patent_doc_number] => 20070104769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Bioabsorbable hemostatic gauze' [patent_app_type] => utility [patent_app_number] => 11/591154 [patent_app_country] => US [patent_app_date] => 2006-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7223 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20070104769.pdf [firstpage_image] =>[orig_patent_app_number] => 11591154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4894004 [patent_doc_number] => 20080103103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'Reagents and methods to treat ocular diseases and infection' [patent_app_type] => utility [patent_app_number] => 11/590617 [patent_app_country] => US [patent_app_date] => 2006-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11098 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20080103103.pdf [firstpage_image] =>[orig_patent_app_number] => 11590617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10897617 [patent_doc_number] => 08920827 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-30 [patent_title] => 'Keratin bioceramic compositions' [patent_app_type] => utility [patent_app_number] => 11/549748 [patent_app_country] => US [patent_app_date] => 2006-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 7127 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11549748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5193581 [patent_doc_number] => 20070082065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Therapeutic composition for the treatment of dry eye syndrome' [patent_app_type] => utility [patent_app_number] => 11/546088 [patent_app_country] => US [patent_app_date] => 2006-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4125 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082065.pdf [firstpage_image] =>[orig_patent_app_number] => 11546088 [rel_patent_id] =>[rel_patent_doc_number] =>)